.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Management of localized myxoid liposarcoma has traditionally required a standard preoperative radiation dose of 50 Gy. However, the long-term results of the DOREMY trial suggest a new standard of care. Specifically, myxoid liposarcoma radiotherapy dose reduction to 36 Gy achieves exceptional local control while significantly minimizing treatment-related morbidity.
The DOREMY trial enrolled 90 patients across nine tertiary sarcoma centers. Each patient received 36 Gy in once-daily 2-Gy fractions before surgical resection. Furthermore, the 5-year follow-up data revealed a local recurrence-free survival rate of 97.4%. Consequently, this lower dose does not appear to compromise oncological safety. Additionally, the overall survival rate at five years was 88.5%, reinforcing the long-term viability of this de-escalated regimen.
Minimizing side effects is a primary goal of dose reduction. In this study, 21% of patients experienced wound complications. Only 16% of these individuals required further surgical intervention. Moreover, late toxic effects remained remarkably low. Only 3% of participants reported grade 3 late toxicity. These findings suggest that 36 Gy is a safer alternative to the conventional 50 Gy dose. Therefore, patients experience fewer permanent complications like fibrosis or joint stiffness.
Myxoid liposarcoma is uniquely radiosensitive compared to other soft tissue sarcomas. This biological characteristic allows for effective tumor volume reduction at lower doses. Given that phase 3 trials are impractical for such rare cancers, these phase 2 findings provide high-level evidence. Clinicians should discuss this 36 Gy approach with patients to optimize long-term quality of life. This strategy balances effective tumor management with a superior safety profile.
The DOREMY protocol uses a reduced total dose of 36 Gy delivered in 18 fractions. This is significantly lower than the standard 50 Gy dose delivered in 25 fractions for other soft tissue sarcomas.
No, this reduction specifically applies to translocation-confirmed myxoid liposarcoma. This subtype is exceptionally sensitive to radiation, unlike other varieties like pleomorphic liposarcoma.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Refer to the latest local and national guidelines for clinical practice.
References
Lansu J et al. Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: The Phase 2 DOREMY Nonrandomized Clinical Trial. JAMA Oncol. 2026 May 16. doi: 10.1001/jamaoncol.2026.1577. PMID: 42141895.
Lansu J, et al. Preoperative radiotherapy dose reduction in patients with myxoid liposarcoma: Results of the DOREMY trial. JAMA Oncol. 2020;6(12):e205864.
National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology: Soft Tissue Sarcoma. Version 2.2024.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A long-term analysis of the DOREMY trial confirms 36 Gy preoperative radiotherapy provides excellent local control for myxoid liposarcoma with low toxicity....
2 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
